(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-N-[1-[(4R)-4-[[(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-[methyl-(1-methylpyrazol-3-yl)carbamoyl]-4-oxoazetidine-1-carbonyl]amino]-4-(2,5-dimethylphenyl)butyl]pyrazol-3-yl]-1-N-[(1R)-1-(2-fluorophenyl)propyl]-2-N-methyl-4-oxoazetidine-1,2-dicarboxamide
C52H59FN14O6 — CID 156524553
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-N-[1-[(4R)-4-[[(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-[methyl-(1-methylpyrazol-3-yl)carbamoyl]-4-oxoazetidine-1-carbonyl]amino]-4-(2,5-dimethylphenyl)butyl]pyrazol-3-yl]-1-N-[(1R)-1-(2-fluorophenyl)propyl]-2-N-methyl-4-oxoazetidine-1,2-dicarboxamide
(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-N-[1-[(4R)-4-[[(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-[methyl-(1-methylpyrazol-3-yl)carbamoyl]-4-oxoazetidine-1-carbonyl]amino]-4-(2,5-dimethylphenyl)butyl]pyrazol-3-yl]-1-N-[(1R)-1-(2-fluorophenyl)propyl]-2-N-methyl-4-oxoazetidine-1,2-dicarboxamide (PubChem CID 156524553) has the molecular formula C52H59FN14O6 and a molecular weight of 995.13 g/mol. Its IUPAC name is (2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-N-[1-[(4R)-4-[[(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-[methyl-(1-methylpyrazol-3-yl)carbamoyl]-4-oxoazetidine-1-carbonyl]amino]-4-(2,5-dimethylphenyl)butyl]pyrazol-3-yl]-1-N-[(1R)-1-(2-fluorophenyl)propyl]-2-N-methyl-4-oxoazetidine-1,2-dicarboxamide.
Molecular Properties
| Compound Name | (2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-N-[1-[(4R)-4-[[(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-[methyl-(1-methylpyrazol-3-yl)carbamoyl]-4-oxoazetidine-1-carbonyl]amino]-4-(2,5-dimethylphenyl)butyl]pyrazol-3-yl]-1-N-[(1R)-1-(2-fluorophenyl)propyl]-2-N-methyl-4-oxoazetidine-1,2-dicarboxamide |
|---|---|
| PubChem CID | 156524553 |
| Molecular Formula | C52H59FN14O6 |
| Molecular Weight | 995.13 g/mol |
| Exact Mass | 994.47 |
| IUPAC Name | (2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-N-[1-[(4R)-4-[[(2S,3R)-3-[(2-amino-4-pyridinyl)methyl]-2-[methyl-(1-methylpyrazol-3-yl)carbamoyl]-4-oxoazetidine-1-carbonyl]amino]-4-(2,5-dimethylphenyl)butyl]pyrazol-3-yl]-1-N-[(1R)-1-(2-fluorophenyl)propyl]-2-N-methyl-4-oxoazetidine-1,2-dicarboxamide |
| SMILES | CC[C@@H](NC(=O)N1C(=O)[C@H](Cc2ccnc(N)c2)[C@H]1C(=O)N(C)c1ccn(CCC[C@@H](NC(=O)N2C(=O)[C@H](Cc3ccnc(N)c3)[C@H]2C(=O)N(C)c2ccn(C)n2)c2cc(C)ccc2C)n1)c1ccccc1F |
| InChI | InChI=1S/C52H59FN14O6/c1-7-39(34-11-8-9-12-38(34)53)58-51(72)66-46(37(47(66)68)27-33-17-21-57-42(55)29-33)50(71)64(6)44-19-24-65(61-44)22-10-13-40(35-25-30(2)14-15-31(35)3)59-52(73)67-45(49(70)63(5)43-18-23-62(4)60-43)36(48(67)69)26-32-16-20-56-41(54)28-32/h8-9,11-12,14-21,23-25,28-29,36-37,39-40,45-46H,7,10,13,22,26-27H2,1-6H3,(H2,54,56)(H2,55,57)(H,58,72)(H,59,73)/t36-,37-,39-,40-,45+,46+/m1/s1 |
| InChIKey | XLAJRHQTNNYXHY-AZNOIOEASA-N |
| XLogP | 5.18 |
| TPSA | 252.90 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 73 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 995.13 |
| LogP ≤ 5 | 5.18 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156524553 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.